Maxim Group Maintains Mainz Biomed(MYNZ.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsMar 28 18:31 ET

Strategic Collaboration and Innovative Biomarkers Drive Buy Rating for Mainz Biomed

TipRanksMar 21 08:09 ET

Mainz Biomed Analyst Ratings

BenzingaFeb 14 11:25 ET

Maxim Group Initiates Coverage On Mainz Biomed With Buy Rating, Announces Price Target of $14

BenzingaFeb 14 11:25 ET

Maxim Group Initiates Mainz Biomed(MYNZ.US) With Buy Rating, Announces Target Price $14

Moomoo NewsFeb 14 08:32 ET

Mainz Biomed Analyst Ratings

BenzingaNov 25, 2024 07:00 ET

H.C. Wainwright Downgrades Mainz Biomed(MYNZ.US) to Hold Rating

Moomoo NewsNov 25, 2024 06:33 ET

Mainz Biomed Analyst Ratings

BenzingaApr 12, 2024 09:58 ET

Analysts' Top Healthcare Picks: Mainz Biomed B.V. (MYNZ), Century Therapeutics (IPSC)

TipRanksApr 12, 2024 06:25 ET

Mainz Biomed Analyst Ratings

BenzingaMar 6, 2024 12:04 ET

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $3

BenzingaMar 6, 2024 12:04 ET

Analysts Are Bullish on Top Healthcare Stocks: Iterum Therapeutics (ITRM), Mainz Biomed B.V. (MYNZ)

TipRanksMar 6, 2024 11:40 ET

Mainz Biomed B.V.: Buy Rating With High CRC Detection Success and AI Integration

TipRanksDec 5, 2023 14:55 ET

Analysts Are Bullish on Top Healthcare Stocks: Mainz Biomed B.V. (MYNZ), Agile Therapeutics (AGRX)

TipRanksNov 21, 2023 12:20 ET

Mainz Biomed Analyst Ratings

BenzingaNov 21, 2023 07:47 ET

Analysts Offer Insights on Healthcare Companies: Mainz Biomed B.V. (MYNZ), Xencor (XNCR) and Biotricity (BTCY)

TipRanksNov 20, 2023 06:30 ET

HC Wainwright & Co. Maintains Buy on Mainz Biomed, Lowers Price Target to $5

BenzingaNov 20, 2023 06:11 ET

Mainz Biomed Analyst Ratings

BenzingaNov 20, 2023 06:09 ET

Cantor Fitzgerald Reiterates Overweight on Mainz Biomed, Maintains $9 Price Target

BenzingaSep 26, 2023 11:46 ET

Mainz Biomed Analyst Ratings

BenzingaSep 26, 2023 11:45 ET